- This event has passed.
HUPO World Congress
December 4 - December 8
VISIT SEER AT HUPO World Congress 2022, Booth #406
December 4-8, 2022 | Cancun, Mexico
We are pleased to join you at HUPO 2022 to learn more about your research discoveries and needs and share with you how Seer’s automated, unbiased proteomics platform and proprietary nanoparticles offer deep, rapid proteomics studies at scale, providing researchers an exciting new lens on the proteome.
Please plan to join our lunch seminar and check out these posters and presentations featuring Seer technology.
Seer Lunch Seminar – Wednesday, December 6th, 2022
Next Generation Proteomics: the future of plasma biomarker discovery with the Proteograph™ Product Suite
Unlocking a new dimension in plasma proteomics biomarker discovery with deep unbiased proteomics at scale.
Bruce Wilcox, Ph.D.
VP of Proteomics
Evaluation of the Proteograph™ Product Suite for analysis of platelet-rich plasma (PRP): a hidden gem for biomarker discovery.
Hugo Gagnon, Ph.D.
CSO, PhenoSwitch Bioscience
A division of Allumiqs
A Highly Scaled Proteomic Discovery Study for Prostate Cancer Diagnostic Signatures Using Proteograph Technology with Trapped Ion Mobility Mass Spectrometry.
Mark R. Flory, Ph.D.
Knight Cancer Institute, CEDAR Center
Oregon Health and Science University
Monday, December 5
A Cloud-scalable Software Suite for Large-Scale Proteogenomics Data Analysis and Visualization
Poster | PP01.159
Tuesday, December 6
Deep plasma protein profiling in Alzheimer’s disease (AD) with a novel unbiased and scalable proteogenomics approach.
Poster | PP02.129
LC-MS Data Analysis Pipelines: Scaling beyond the desktop environment
Poster | PP02.74
Wednesday, December 7
Deep and unbiased proteomics analysis reveals differences between serum and plasma proteome in matched donors.
Poster | PP03.140
Experimental & Computational Approach to Profile Nanoparticle-Protein Interactions for Deep Plasma Proteomics.
Poster | PP03.142
Enhanced workflow enabling next generation nanoparticle-based plasma proteomics with improved detection of low abundance chemokines
Poster | PP03.130
The nanoparticle-based plasma proteomics workflow enables the investigation of glycoproteome.
Poster | PP03.153
Matrix-matched calibration curves provide verification of quantitative data-independent acquisition techniques for deep plasma proteomics
Poster | PP03.59
A large scale multi-cancer, multi-omics biomarker study of >1,800 subjects incorporating deep unbiased plasma proteomics
Poster | PP03.145
A Highly Scaled Proteomic Discovery Study for Prostate Cancer Diagnostic Signatures Using Proteograph Technology with Trapped Ion Mobility Mass Spectrometry
Poster | PP03.125
Integrated Plasma Multi-omics using nano-particle technology and single-shot capillary MS
Poster | PP03.137